显微神经学
医学
糖尿病
心率
内科学
心力衰竭
人口
2型糖尿病
心脏病学
2型糖尿病
交感神经系统
血压
内分泌学
压力反射
环境卫生
作者
Raffaella Dell’Oro,Fosca Quarti‐Trevano,Stefano Ciardullo,Gianluca Perseghin,Giuseppe Mancia,Guıdo Grassı
标识
DOI:10.1007/s10286-024-01054-z
摘要
Abstract Purpose Clinical trials have shown that in type 2 diabetes mellitus (T2D) resting office heart rate (HR) values > 70 beats/minute are associated with an increased cardiovascular risk, a worse prognosis and an unfavorable outcome. The present study was aimed at investigating whether the above mentioned treshold HR values reflect a sympathetic overdrive of marked degree. Methods In 58 T2D patients (age range: 39–57 years) without signs of autonomic neuropathy and in 52 age-matched healthy controls, we assessed muscle sympathetic nerve activity (MSNA, microneurography) and venous plasma norepinephrine (NE, HPLC), subdividing the study population in different subgroups according to their clinic and 24-h HR values. Results In T2D progressively greater clinic and 24-h HR values were accompanied by progressive increases in MSNA and NE. HR cutoff values indicated by clinical trials as associated with an increased cardiovascular risk (> 70 beats/minute) were accompanied by MSNA values significantly higher than those detected in patients with lower HR, this being the case also for NE. In T2D both MSNA and NE were significantly related to clinic ( r = 0.93, P < 0.0001 and r = 0.87, P < 0.0001, respectively) and 24-h ( r = 0.92, P < 0.0001 and r = 0.84, P < 0.0001, respectively) HR. The MSNA and NE behaviour observed in T2D was not detected in healthy controls. Conclusions In T2D clinic HR values allow to detect patients with a greater sympathetic overactivity. Considering the adverse clinical impact of the sympathetic overdrive on prognosis, our data emphasize the need of future studies investigating the potential usefulness of lifestyle and pharmacological interventions exerting sympathomodulatory effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI